Products Categories
CAS No.: | 2363-58-8 |
---|---|
Name: | Epitiostanol |
Molecular Structure: | |
Formula: | C19H30OS |
Molecular Weight: | 306.51 |
Synonyms: | 5α-Androstan-17b-ol, 2α,3α-epithio- (7CI,8CI);10275S;2α,3α-Epithio-5α-androstan-17β-ol;NSC 194684;Thiodrol; |
Density: | 1.138 g/cm3 |
Melting Point: | 127-128° |
Boiling Point: | 424.407 °C at 760 mmHg |
Flash Point: | 206.05 °C |
Solubility: | 1.2mg/L(37 oC) |
PSA: | 45.53000 |
LogP: | 4.48390 |
The Epitiostanol, with the CAS registry number 2363-58-8, is also known as 2α,3α-Epithio-5α-androstan-17β-ol. It belongs to the product categories of Inhiitors; Intermediates & Fine Chemicals; Pharmaceuticals; Steroids; Sulfur & Selenium Compounds. This chemical's molecular formula is C19H30OS and molecular weight is 306.51. What's more, its systematic name is (2α,3α,5α,17β)-2,3-Epithioandrostan-17-ol. Its classification code is Reproductive Effect. This chemical is is an anabolic steroid. It is used in therapy of advanced breast cancer.
Physical properties of Epitiostanol are: (1)ACD/LogP: 4.743; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 4.74; (4)ACD/LogD (pH 7.4): 4.74; (5)ACD/BCF (pH 5.5): 2371.27; (6)ACD/BCF (pH 7.4): 2371.27; (7)ACD/KOC (pH 5.5): 9065.84; (8)ACD/KOC (pH 7.4): 9065.84; (9)#H bond acceptors: 1; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Polar Surface Area: 45.53 Å2; (13)Index of Refraction: 1.58; (14)Molar Refractivity: 89.579 cm3; (15)Molar Volume: 269.359 cm3; (16)Polarizability: 35.512×10-24cm3; (17)Surface Tension: 46.314998626709 dyne/cm; (18)Density: 1.138 g/cm3; (19)Flash Point: 206.05 °C; (20)Enthalpy of Vaporization: 78.403 kJ/mol; (21)Boiling Point: 424.407 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: O[C@H]5CC[C@H]4[C@H]3[C@@H]([C@@]2([C@H](C[C@@H]1S[C@@H]1C2)CC3)C)CC[C@@]45C
(2)Std. InChI: InChI=1S/C19H30OS/c1-18-8-7-14-12(13(18)5-6-17(18)20)4-3-11-9-15-16(21-15)10-19(11,14)2/h11-17,20H,3-10H2,1-2H3/t11-,12-,13-,14-,15-,16+,17-,18-,19-/m0/s1
(3)Std. InChIKey: OBMLHUPNRURLOK-XGRAFVIBSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | intraperitoneal | > 150mg/kg (150mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 2983, 1973. |
mouse | LD | oral | > 10gm/kg (10000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 805, 1973. |
mouse | LD | subcutaneous | > 10gm/kg (10000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) SKIN AND APPENDAGES (SKIN): HAIR: OTHER ENDOCRINE: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 805, 1973. |
mouse | LD50 | intraperitoneal | 1160mg/kg (1160mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 805, 1973. |
rat | LD | oral | > 6gm/kg (6000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LIVER: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 805, 1973. |
rat | LD | subcutaneous | > 5gm/kg (5000mg/kg) | ENDOCRINE: OTHER CHANGES LIVER: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 805, 1973. |
rat | LDLo | intraperitoneal | 5gm/kg (5000mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 805, 1973. |